The Crispr Technology Market size was US$ 3.3 Billion in 2022. Covid-19's impacts have been unprecedented and staggering on a global scale, with the pandemic leading to positive demand shocks for the CRISPR technology market across all domains and regions. Between 2023 and 2031, the market is projected to reach US$ 20.2 Billion by 2031, growing at a CAGR of 22.3 % during the forecast period (2023-2031) according to a new report by IMIR Market Research.
CRISPR technology, short for Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene editing tool that allows scientists to make precise modifications to the DNA of living organisms. It utilizes a CRISPR-associated protein called Cas9, along with a guide RNA, to target specific DNA sequences and induce changes such as gene insertions, deletions, or modifications. CRISPR technology has revolutionized genetic research and holds immense potential for various applications in healthcare, agriculture, and other fields.
The CRISPR technology market has a wide scope that encompasses various sectors, including biomedical, agricultural, and industrial applications. In the biomedical field, CRISPR technology is being explored for gene therapy, drug discovery, and precision medicine, offering the potential to revolutionize disease treatment. In agriculture, CRISPR has the capacity to improve crop yields, enhance disease resistance, and create genetically modified organisms. In the industrial sector, CRISPR can be applied to biofuel production, environmental remediation, and bioproduction processes. The market is primarily driven by the growing demand for gene editing tools to address genetic diseases and the advancements in CRISPR technology, which continue to enhance its precision, efficiency, and versatility, leading to wider adoption and exploration of its applications across different industries. Bill and Melinda Gates Foundation has indeed awarded funding to CRISPR Therapeutics. In 2017, the foundation announced that it would provide financial support to CRISPR Therapeutics to develop CRISPR-based therapies for sickle cell disease and HIV. The funding aimed to accelerate the development of these potential treatments and address the significant global burden of these diseases.
Advancements in Gene Editing Technology:
Advancements in gene editing technology, specifically CRISPR, have revolutionized the field of genetic engineering by significantly improving the efficiency, specificity, and scalability of gene editing processes. The continuous refinement of CRISPR systems has led to enhanced editing capabilities, enabling scientists to precisely target and modify specific genes or DNA sequences with greater accuracy and efficacy. Additionally, the increased specificity of CRISPR systems has minimized off-target effects, ensuring that gene editing occurs only at the intended sites, enhancing the safety and reliability of the technology. Furthermore, the scalability of CRISPR technology has expanded its potential applications across various fields, including therapeutics, agriculture, and industrial biotechnology.
The ability to edit multiple genes simultaneously, known as multiplexing, has opened up new avenues for complex genetic modifications and advanced research possibilities. Overall, these advancements in CRISPR technology have significantly broadened its potential applications and increased the feasibility of developing CRISPR-based therapies, paving the way for groundbreaking advancements in medicine, agriculture, and beyond. CRISPR has shown promise in the field of gene therapy. In 2021, the FDA approved the first-ever CRISPR-based gene therapy called Zolgensma for the treatment of spinal muscular atrophy in pediatric patients, marking a significant milestone in the application of CRISPR technology in the clinic.
Increasing development of novel therapeutics using CRISPR is growing market:
Another driver of the CRISPR technology market is the increasing development of novel therapeutics using CRISPR. This includes the development of CRISPR-based therapies such as gene therapies, cell therapies, and immunotherapies. These therapies have the potential to address a wide range of diseases and disorders and offer significant advantages over traditional treatments. As more and more companies invest in the development of CRISPR-based therapeutics, the demand for CRISPR technology is expected to increase, driving the growth of the market.
Throughout the forecast period, biomedical is anticipated to hold a sizable market share:
According to this market tendency, the biomedical sector is anticipated to have a significant impact on the market for CRISPR technology in the near future. The term "biomedical" describes the application of biological and physiological concepts to clinical medicine, which includes the identification, management, and avoidance of illnesses and conditions.
The biomedical industry's use of CRISPR technology has demonstrated great promise for the creation of innovative therapies and treatments for a variety of illnesses and disorders. In order to cure genetic disorders, faulty genes can be fixed or replaced with healthy ones using CRISPR technology. By focusing on particular genes linked to a person's illness, CRISPR can also be used to create personalized medicine, leading to more precise and effective treatments.
Furthermore, the biomedical industry has a large market size and is constantly growing due to the increasing prevalence of chronic diseases and the aging population worldwide. As a result, the demand for effective and personalized treatments is increasing, which is expected to drive the growth of the CRISPR technology market.
Scope of Crispr Technology Market Report:
A recent market research report added to repository of Intellectual Market Insights Research is an in-depth analysis of Global Crispr Technology Market. On the basis of historic growth analysis and current scenario of Crispr Technology market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global Crispr Technology market. This further helps users with their developmental strategy.
This report examines all the key factors influencing growth of global Crispr Technology market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Crispr Technology market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, pricing strategies, innovation possibilities and much more.
The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
Market Restraining Factors:
High costs of CRISPR technology of the market:
The high expense of CRISPR technology is one of the key factors limiting the market for this technology. Although CRISPR has the potential to completely change the medical industry, it is still very expensive to create and use. Due to the technology's complexity and the requirement for specialised tools and knowledge to carry out the gene editing procedure, CRISPR is expensive. As a consequence, many organisations, especially those with low financial resources, may find the expense of using CRISPR in research and clinical settings to be prohibitive. This could slow down the adoption of CRISPR technology, especially in nations with constrained healthcare funds, which could obstruct the market's expansion for the technology. The price of CRISPR is anticipated to progressively drop over time, though, due to ongoing technological advancements and heightened corporate competition.
Crispr Technology Market Players Analysis:
- Thermo Fisher Scientific Inc.
- CRISPR Therapeutics AG
- Intellia Therapeutics Inc.
- Editas Medicine Inc.
- Sangamo Therapeutics Inc.
- Caribou Biosciences Inc.
- Precision Biosciences Inc.
- Cellectis SA
- Synthego Corporation
- Horizon Discovery Group plc
- GenScript Biotech Corporation
- Merck KGaA (EMD Millipore)
- New England Biolabs Inc.
- Integrated DNA Technologies, Inc.
Crispr Technology Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2023-2031 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- In June 2023, Caribou Biosciences, a prominent player in the CRISPR technology market, has achieved a major breakthrough. The company has commenced clinical trials for their CRISPR-based cancer therapeutics, signaling a significant advancement in the field.
- In June 2023, Vertex Pharmaceuticals has achieved a significant milestone in the CRISPR technology market. The company's CRISPR-based drug, designed to treat a genetic form of cystic fibrosis, has won positive results in clinical trials. Following these successful trial outcomes, Vertex Pharmaceuticals has been granted a Prescription Drug User Fee Act (PDUFA) date, bringing the drug two steps closer to regulatory approval.
- In June 2023, Parse Biosciences, a prominent player in the CRISPR technology market, has made an exciting announcement. The company has launched a groundbreaking product called CRISPR-Detect. This innovative solution enables researchers to detect and quantify specific DNA sequences with high accuracy using CRISPR technology.
Crispr Technology Market Segmentation Analysis:
Enzymes: Enzymes are one of the key components of CRISPR technology. The enzymes used in CRISPR systems are called nucleases, which are responsible for cutting and editing specific sequences of DNA. The two most commonly used enzymes in CRISPR are Cas9 and Cpf1. These enzymes can be purchased from various suppliers and are used in a wide range of applications, from basic research to therapeutic development.Kits and Reagents
Kits and Reagents: Kits and Reagents are used in CRISPR to deliver the guide RNA components into cells. Plasmids are circular DNA molecules that can replicate independently from chromosomal DNA, while vectors are DNA molecules used to transfer foreign genetic material into another cell. Kits and Reagents can be customized to target specific genes or cell types, making them essential tools for developing CRISPR-based therapies.
Guide RNA: Cas9 and guide RNA are the two most critical components of the CRISPR system. Cas9 is the nuclease that cuts the DNA, while guide RNA directs Cas9 to the specific location in the DNA that needs to be edited. Cas9 and guide RNA can be delivered into cells using plasmids, vectors, or other delivery methods. These components can be purchased from various suppliers or produced in-house by researchers and companies.
Others: The "Others" category includes other products or components used in the CRISPR technology market, such as delivery systems, gene synthesis services, and screening tools. Delivery systems are used to deliver CRISPR components into cells, while gene synthesis services are used to generate DNA sequences for gene editing. Screening tools are used to identify cells that have been successfully edited using CRISPR. These products and components play a critical role in the development and application of CRISPR technology.By Fabric Apparel.
Biomedical: The biomedical application of CRISPR technology involves the use of gene editing to develop new treatments for genetic disorders and other diseases. CRISPR technology can be used to edit genes that cause diseases, or to add, delete or replace DNA sequences to treat or cure diseases. Biomedical applications of CRISPR technology include gene therapy, drug discovery, and personalized medicine.
Agricultural: CRISPR technology is also being used in agriculture to develop crops with desirable traits, such as disease resistance, drought tolerance, and increased yield. By editing specific genes in plants, scientists can create crops that are more resistant to pests and diseases, can grow in harsh environments, and require less water and other resources. Agricultural applications of CRISPR technology have the potential to address the growing demand for food and the challenges posed by climate change.
Industrial: CRISPR technology is also being used in various industrial applications, such as the production of biofuels, pharmaceuticals, and other chemicals. By editing genes in microorganisms, such as bacteria and yeast, scientists can create strains that are more efficient at producing these substances. Industrial applications of CRISPR technology have the potential to improve the efficiency and sustainability of various industries.
Others: The "Others" category includes other areas of application where CRISPR technology is being used, such as research, conservation, and forensic science. CRISPR technology can be used to study the function of genes in various organisms, to preserve endangered species, and to identify individuals in forensic investigations.
By End User
Pharmaceutical Companies: Pharmaceutical companies are among the major end-users of CRISPR technology. They use CRISPR technology to develop new therapies for various diseases, including genetic disorders, cancer, and infectious diseases. CRISPR technology enables pharmaceutical companies to create targeted therapies that can selectively edit genes and modify disease-causing mutations, providing more effective treatments for patients.
Academics Research Organizations: Academic research organizations, including universities, research institutions, and government agencies, are significant users of CRISPR technology. Academic researchers use CRISPR to study the function of genes and to develop new techniques for gene editing. The academic community plays a critical role in advancing the field of CRISPR technology and exploring its potential applications.
Agricultural Biotechnology Companies: Agricultural biotechnology companies use CRISPR technology to develop new crop varieties with desirable traits, such as improved yield, disease resistance, and drought tolerance. By editing specific genes in plants, agricultural biotechnology companies can create crops that can withstand harsh environmental conditions, require less water and other resources, and are less vulnerable to pests and diseases.
Contract Research Organizations: Contract research organizations (CROs) provide research and development services to pharmaceutical, biotechnology, and other companies. CROs use CRISPR technology to conduct preclinical studies, drug discovery, and other research activities. They also provide contract manufacturing services for CRISPR-based therapies.
Biopharmaceutical Companies: Biopharmaceutical companies use CRISPR technology to develop new therapies for various diseases. CRISPR technology allows them to create precise and targeted therapies that can selectively edit genes and modify disease-causing mutations. Biopharmaceutical companies also use CRISPR for drug discovery and to study disease mechanisms.
The report also helps in understanding Global Crispr Technology Market dynamics, structure by analyzing the market segments, and project the Global Crispr Technology Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Crispr Technology Market make the report investor’s guide.
Estimated Forecast Year
CAGR of 22.3 % from 2023 to 2031
By Product, By Applications, By End-User, , By Region
- Kits and Reagents
- Guide RNA
- Pharmaceutical companies and Biotechnology Companies
- Academics and Government Research Institutes
- Others (CROs etc.)
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, ASEAN, Rest of Asia-Pacific)
- LAMEA (Latin America, Middle East, Africa)
Here are some regional snapshots of the CRISPR technology market :
North America: North America is the largest market for CRISPR technology, driven by the presence of a large number of pharmaceutical and biotechnology companies, academic research institutions, and government funding for research and development. The United States is the major contributor to the growth of the North American CRISPR technology market, followed by Canada.
Europe: Europe is the second-largest market for CRISPR technology, driven by the increasing focus on precision medicine and the growing demand for genetically modified crops. The United Kingdom, Germany, and France are the major contributors to the growth of the European CRISPR technology market.
Asia-Pacific: The Asia-Pacific region is the fastest-growing market for CRISPR technology, driven by the increasing adoption of CRISPR-based gene editing technologies in various applications, including medicine, agriculture, and research. China, Japan, and India are the major contributors to the growth of the Asia-Pacific CRISPR technology market.
Latin America: Latin America is a growing market for CRISPR technology, driven by the increasing investments in research and development by pharmaceutical and biotechnology companies. Brazil, Mexico, and Argentina are the major contributors to the growth of the Latin American CRISPR technology market.
Middle East and Africa: The Middle East and Africa region is a developing market for CRISPR technology, driven by the increasing investments in research and development and the growing demand for genetically modified crops. South Africa, Saudi Arabia, and the United Arab Emirates are the major contributors to the growth of the Middle East and Africa CRISPR technology market.
Global Crispr Technology Market Regional Analysis:
North America accounted for the highest xx% market share in terms of revenue in the Crispr Technology market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Crispr Technology. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Crispr Technology companies in economies such as Japan and China.
The objective of the report is to present comprehensive analysis of Global Crispr Technology Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Crispr Technology Market Report is also available for below Regions and Country Please Ask for that
- Rest of Europe
- South Korea
- Rest Of APAC
- Rest of South America
Middle East and Africa
- Saudi Arabia
- South Africa
- Rest Of MEA
Key Industry Developments:
- In October 2022, A mechanical bacteriophage of the second generation was created by iNtron Biotechnology. In addition to the previously revealed customised CRISPR/Cas system for bacteriophage engineering advancement, the random transpose mutagenesis technology is applied to the bacteriophage genome.
- In September 2022, Vertex and CRISPR Therapeutics expect to finish the offer by the end of Q1 2023 after finishing a conversation with the US Food and Drug Administration for the submission of exa-cel in November 2022.
- In May 2021, A non-exclusive licence deal between ERS Genomics Ltd. and GenScript Biotech Corporation allows GenScript access to ERS Genomics' CRISPR/Cas9 patent portfolio.
- In March 2021, A COVID-19 test based on CRISPR that provides results in 30 minutes was created by researchers from Nanyang Technological University in Singapore. Even after the virus has mutated, this technique still finds it. This would motivate additional participants to take advantage of this chance..
The report will cover the qualitative and quantitative data on the CRISPR technology market . The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.
Report Scope and Segmentations:
Estimated Forecast Year
CAGR of 25.3%from 2023 to 2031.
By Product, By Application, By End User, By Region
- Plasmid and Vector
- Cas9 and Guide RNA
By End User
- Pharmaceutical companies
- Academics Research Organizations
- Agricultural Biotechnology Companies
- Contract Research Organizations
- Biopharmaceutical Companies
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, ASEAN, Rest of Asia-Pacific)
- Latin America
- Middle East and Africa
Points Covered in the Report:
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 12 years data history and forecast.
The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase:
To gain insightful analyses of the Crispr Technology market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the Crispr Technology market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the Crispr Technology market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Research Scope of Crispr Technology Market:
- Historic year: 2018- 2021
- Base year: 2022
- Forecast: 2023 to 2031
- Representation of Market revenue in USD Million
Crispr Technology Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: